운카린산 C에 의해 성숙화된 수지상세포, 이를 함유하는 면역치료용 조성물, 및 운카린산 C를 이용한 성숙 수지상세포의 제조 방법
    1.
    发明授权
    운카린산 C에 의해 성숙화된 수지상세포, 이를 함유하는 면역치료용 조성물, 및 운카린산 C를 이용한 성숙 수지상세포의 제조 방법 失效
    由非卡那酸C,由含有细胞的免疫组织组成的致敏细胞以及使用非卡那酸制备成熟细胞的方法C

    公开(公告)号:KR100954887B1

    公开(公告)日:2010-04-28

    申请号:KR1020090051422

    申请日:2009-06-10

    CPC classification number: C12N5/064

    Abstract: PURPOSE: Matured dendritic cells by uncarinic acid C are provided to enhance the differentiation of nave T cells to Th1 cells and to induce specific reaction. CONSTITUTION: A mutured dendritic cell is obtained by adding uncarinic acid C to immature dendritic cells and culturing. A composition for immunotherapy contains dendritic cells, T cells differentiated therefrom, or cytokine produced thereby. The uncarinic acid C is isolated from Uncaria rhynchophylla. A method for producing the matured dendritic cells comprises: a step of adding uncarinic acid C to immature dendritic cells by intravenous or hypodermic infection, and a step of culturing the dendritic cells.

    Abstract translation: 目的:提供通过脱羧酸C的成熟树突状细胞,以增强纳瓦T细胞与Th1细胞的分化并诱导特异性反应。 构成:通过向未成熟的树突状细胞中加入非卡洛芬酸C并进行培养获得了一种突变的树突状细胞。 用于免疫治疗的组合物包含树突状细胞,从其分化的T细胞或由此产生的细胞因子。 脱羧酸C分离自钩藤草(Uncaria rhynchophylla)。 一种生产成熟树突状细胞的方法包括:通过静脉内或皮下感染向未成熟树突细胞中添加非卡里酸C的步骤和培养树突状细胞的步骤。

Patent Agency Ranking